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laine Fuchs has collected many 
awards in her 30 years researching 
mammalian skin development, 
but it’s hard to beat the two prizes she 
received in late 2009. Shortly before 
winning the prestigious L’Oreál-UNESCO 
award for women in science, Fuchs was 
awarded the National Medal of Science—
the US’s highest honor for outstanding 
scientifi  c contributions.
After studying bacterial sporulation 
as a PhD student with Charles Gilvarg at 
Princeton, Fuchs joined Howard Green’s 
laboratory at MIT, where she investigated 
the expression of keratins in differentiating 
skin cells (1, 2). Fuchs then returned to her 
native Illinois to begin her own laboratory 
at the University of Chicago, and stayed 
for more than 20 years before moving to 
The Rockefeller University in New York 
in 2002. Fuchs’ research has touched on 
many aspects of skin differentiation and 
function. Asked to pick her favorite work, 
she chooses her pioneering use of mouse 
genetics to identify mutant keratins as 
the cause of several human skin diseases 
(3, 4). She also mentions the generation 
of super furry mice by expressing a sta-
bilized version of the transcription factor 
-catenin (5) as well as the identifi  cation 
and characterization of a multipotent stem 
cell population in the hair follicle (6, 7). 
In a recent interview, Fuchs discussed her 
latest awards, and explained why the skin 
continues to hold her interest.
ASKING & ANSWERING QUESTIONS
Is it true that you refused to take the 
exam for graduate school entry?
Yes! [laughs] I was graduating near the 
top of my class from a very good univer-
sity and I felt that the Graduate Record 
Examination wasn’t testing my real 
knowledge, but rather how I could per-
form in a written exam. So I decided that 
perhaps they’d appreciate some creative 
writing instead. I wrote three pages ex-
plaining the reasons why I was not going 
to be taking my GRE, and I sent it along 
with my applications.
I got accepted everywhere, but it’s 
quite unlikely that I would be admitted to 
any graduate program in the US today. I 
don’t think professors are as open-minded 
toward rebellious students as they were 
during the Vietnam War era.
How did you decide to go to Howard 
Green’s laboratory for your postdoc?
I had been working on bacterial sporu-
lation and, in the course of that, I studied 
bacterial cell walls. Many antibiotics tar-
get the enzymes that synthesize cell walls, 
and that medical aspect was what I really 
liked about my science.
To maintain my interest in biomedi-
cal research, I decided to switch to the 
growth and differentiation of human cells, 
but I knew I was going to need a good 
culture system. Howard was a cell culture 
guru—he developed the use of human epi-
dermal cells as well as the 3T3L1 line for 
adipocyte differentiation. Almost everyone 
else was using transformed mammalian 
cells at the time and I thought these were 
great systems to study—I still do.
And you’ve worked on skin ever since—
what has captivated you for so long?
Skin is such a complex organ. We focus on 
the epithelium, but epithelial–mesenchymal 
interactions are very important in dictating 
whether keratinocyte stem cells will stratify 
to make an epidermis or differentiate into a 
sebaceous gland or hair follicle. How does 
that happen? How do you start with a stem 
cell and build a tissue? There are lots of fac-
ets to the problem, ranging from transcrip-
tion to cell–cell and cell–substratum inter-
actions. There’s this endless array of signals 
from the environment that, in a sense, en-
compasses almost every aspect of biology.
So even though we still work on skin 
as a model system, we continue to ask dif-
ferent questions. We spent 10 years working 
on keratins, but if I’d stuck with that, I might 
have burned myself out. I learned early on 
in my career that it’s important to choose 
a problem you’re interested in, even if you 
don’t yet know the technology you need to 
address it. I think people get into ruts when 
they become very good at something and do 
it over and over again. What we’re doing 
now is very different to what we were 
doing several years ago, and we continue to 
try novel and original approaches.
PROGRESS ON MANY FRONTS
One of those original approaches was 
using transgenic mice to link keratins 
with human genetic diseases…
After cloning and sequencing the first 
keratins, we’d begun to hone in on the key 
residues that were critical for the assembly 
of keratin intermediate fi  laments, but we 
couldn’t predict the disease we should be 
looking at from the disrupted keratin 
networks we saw in our cultured skin cells. 
We thought that engineering mice harbor-
ing our dominant-negative keratin gene 
might offer us better clues. We set up trans-
genic mouse technology, but when we got 
our mice expressing mutant keratin, they 
showed no phenotype at all. I thought, “We 
just wasted all this time learning this tech-
nology, and we’re getting nowhere.”
Then one day a technician said, 
“There’s this dead mouse that’s half eaten, 
and it looks like it’s got a severe problem 
with its skin.” We took a look and it was 
expressing whopping amounts of our trans-
gene. We realized that the mom was eating 
every single phenotypic mutant while leav-
ing behind all the nonphenotypic ones. I 
gave [laboratory members] Bob Vassar and 
Pierre Coulombe my offi  ce for the night, 
and they babysat until the moms delivered. 
After their preliminary analysis, we sat 
down with a dermatology textbook and it 
was pretty clear: the pathology matched 
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perfectly with epidermolysis bullosa sim-
plex, a blistering skin disorder in humans.
But not everyone believed you at ﬁ  rst?
No. I don’t blame people because diagnos-
ing mice as having a particular human dis-
ease was unconventional at the time. I pre-
sented the work at a large meeting, and the 
chair took the microphone and said, “I don’t 
know what you’ve got, but you certainly 
don’t have EBS.” It took a few moments for 
me to react—it was look-
ing pretty bad. The audi-
ence listened to the chair, 
who continued to declare 
confi  dently that our fi  nd-
ings were rubbish.
But at that point 
Mina Bissell stood up 
and said, “I don’t know 
whether she’s going to be 
right or wrong, but I just 
heard an interesting story, 
and I think we should 
give her the chance to fi  nd 
out.” This broke the ice for UPenn’s chair 
of dermatology, John Stanley, to stand up 
and say, “Actually, I would also diagnose 
the pathology as EBS.” Eight months later, 
we published a paper documenting the 
human genetic basis of EBS, so it didn’t 
take long to prove our hypothesis.
You were one of very few female group 
leaders when you began in Chicago. 
How was that?
A technician from another laboratory came 
down as I was setting up my laboratory, and 
said, “Are you Dr. Fuchs’ new technician?” 
and I had to say, “I am Dr. Fuchs!” There 
were cases where I’d be introduced to the 
seminar speaker as the prettiest member of 
the department—things that would make 
me cringe. I didn’t know what to make of 
these comments, and I’m not sure the men 
knew what to make of having me there.
I didn’t care what my salary was—it 
was more than I’d got as a postdoc— until 
after I was a tenured faculty member, when I 
discovered that my salary was actually lower 
than what they were offering to starting 
assistant professors. It was only after I real-
ized I’d been underpaid all those years that 
I got angry. So there were defi  nitely gender 
issues that could’ve distracted me, but I was 
so thrilled to be able to do my science that 
nothing else seemed to matter so much.
You’ve been a strong advocate for 
women in science, which was recognized 
by your L’Oreál-UNESCO award. Do 
any signiﬁ  cant challenges remain?
Things are enormously better, particularly 
in the US. In general, the door is open for 
women all the way up to being an associate 
professor but it’s still diffi  cult at the upper 
end of the scale—there are 
very few women in leader-
ship positions. And there 
are still women at some 
universities who feel they 
are underpaid, have less 
space, and receive fewer 
privileges than their male 
colleagues. Most major 
universities have gotten the 
message, but I’m not sure 
all the smaller universities 
have followed suit.
HOPE AND CHANGE
The other prize you won recently was 
the National Medal of Science. How 
was your trip to the White House?
Having the President of the United States 
shake my hand and place a medal around 
my neck was a moving experience. It was 
also nice to have not only my husband, but 
also my mother (who’s close to 88 years 
old now), my sister, and eldest nephew 
present. It was particularly thrilling for me 
because President Obama recognizes the 
importance of basic research and science 
education to the future of our country.
Could scientists do a better job of commu-
nicating the importance of their work?
Yes—we need to educate politicians about 
the importance of basic research and in-
creasing the budget for it. [Former con-
gressman] John Porter, at a recent Howard 
Hughes meeting, asked us all, “When was 
the last time you contacted a politician and 
invited them to your laboratory? They need 
to see what scientists are doing.” If politi-
cians don’t understand what we can learn 
from basic research and appreciate its 
importance, why should they support it?
How do you maintain your enthusiasm?
A professor’s role is a combination of 
research and education. I empathize with 
the pain students feel as they initially 
struggle with scientifi  c research, yet there’s 
nothing more gratifying than watching a 
student’s fi   rst experiment work. You see 
them think, “Well, it’s really worth it after 
all. I can do it.” As long as I’m passionate 
about the scientifi  c questions we tackle, I 
don’t think I’ll ever get tired of being a pro-
fessor. It’s the best possible job in the world.
What can we expect next from the 
Fuchs laboratory?
New approaches, of course! We’ve identi-
fi  ed lots of new genes that change their 
expression patterns as stem cells make 
epidermis and hair follicles. But we can’t 
use classical genetics to fi  gure out what all 
these changes mean—a conditional knock-
out mouse takes a couple of years to make, 
and there’s a lot of redundancy in the 
genome. We’re developing new strategies to 
make functional analyses of mouse skin 
development a more tractable process. 
There are many signaling pathways that 
must converge to build and maintain tissues 
during normal development and wound 
repair, and a lot of pathways go awry to 
generate the myriad of human skin disor-
ders, including cancers. We know a little bit 
here and there, yet we still have a lot of 
pieces to fi  ll in. But I love the puzzle!
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Fuchs receives the National Medal of Science 
from President Obama.
“There’s this 
endless array 
of signals 
from the 
environment that 
encompasses 
almost every 
aspect of 
biology.”